CRF test in melancholic depressive patients with partial versus complete relapses: A 2-year follow-up study. (June 2013)

• Record Type: Journal Article
• Authors: Pintor, Luis; Torres, Xavier; Bailles, Eva; Navarro, Victor; de Osaba, María Jesús Martínez; Belmonte, Anna; Gastó, Cristobal
• Is Part Of: Nordic journal of psychiatry. Volume 67:Number 3(2013)
• Page Start: 177
• Page End: 184
• Publication Date: 2013-06
• Subjects: Psychopharmacology -- Periodicals; Psychotherapy -- Periodicals; Psychiatry -- Periodicals; Psychiatry -- Scandinavia -- Periodicals; 616.89
• DOI: 10.3109/08039488.2012.700733
• Languages: English
• ISSNs: 0803-9488

Abstract

<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <p> <italic>Background:</italic> Patients with depressive disorders present abnormalities in the hypothalamic pituitary adrenal (HPA) axis. The effects of a partial relapse with regard to HPA axis has not been studied so far. <italic>Aim:</italic> To assess whether patients with partial relapse have a different neuroendocrine profile compared with those with complete relapse and with those without relapse over a 2-year follow-up. <italic>Methods</italic>: The adrenocorticotropin hormone (ACTH) and cortisol responses to corticotrophin releasing factor (CRF) stimulation was assessed in 62 outpatients diagnosed with unipolar depressive disorder with melancholic features according to DSM-IV. Twenty-three healthy controls were included in the study for comparison. Monthly follow-up visits were performed over a 2-year period after remission; partial and complete relapses were established using the Hamilton Depression Rating Scale (HDRS) and according to Frank's criteria. Fifty-four patients completed the study. A comparative statistical analysis was performed. <italic>Results</italic>: Stratifying the net area under cortisol curve (NAUCC) (µg/ml/min) at three levels—< 150, 150–350 and ≤ 350—significant differences appear between the three depressive groups of patients (non-relapsers, partial relapsers and complete relapsers). Particularly, there are more patients with a NAUCC ≤ 350 who show partial or complete relapses than patients with a NAUCC ≤ 350 who do not relapse (<italic>P</italic> ≤ 0.05). <italic>Conclusions</italic>: Our results show an increasingly altered HPA axis in those depressive patients with complete or partial relapses compared with those who did not relapse or with healthy controls, but there are not differences in HPA axis between partial and complete relapsers.</p> </abstract>